Ara
Toplam kayıt 13, listelenen: 11-13
Predicting response to neoadjuvant therapy with glucose transporter-1 in breast cancer
(Assoc Medica Brasileira, 2023)
OBJECTIVE: Glucose transporter-1 is a marker involved in energy transport in cancer cells. It has been shown to be a poor prognostic factor in many cancer types, including breast cancer. However, there is no satisfactory ...
Dietary acrylamide exposure and cancer risk: A systematic approach to human epidemiological studies
(MDPI, 2023)
Acrylamide, identified by the International Cancer Research Center as a possible carcinogenic compound to humans, is a contaminant formed as a result of the thermal process in many foods, such as coffee, French fries, ...
Metabologenomics and network pharmacology to understand the molecular mechanism of cancer research
(Baishideng Publishing Group Inc. Tutar Y. Metabologenomics and network pharmacology to understand the molecular mechanism of cancer research. World J Clin Cases 2024; 12(3): 474-478 [PMID: 38322468 DOI: 10.12998/wjcc.v12.i3.474], 2024)
In this editorial I comment on the article "Network pharmacological and molecular docking study of the effect of Liu-Wei-Bu-Qi capsule on lung cancer" published in the recent issue of the World Journal of Clinical Cases ...